RU96124465A - METHOD FOR TREATMENT OF PERSISTENT DISADAPTATION PSYCHOPHETIC DISORDERS - Google Patents

METHOD FOR TREATMENT OF PERSISTENT DISADAPTATION PSYCHOPHETIC DISORDERS

Info

Publication number
RU96124465A
RU96124465A RU96124465/14A RU96124465A RU96124465A RU 96124465 A RU96124465 A RU 96124465A RU 96124465/14 A RU96124465/14 A RU 96124465/14A RU 96124465 A RU96124465 A RU 96124465A RU 96124465 A RU96124465 A RU 96124465A
Authority
RU
Russia
Prior art keywords
persistent
treatment
disorders
psychophetic
disadaptation
Prior art date
Application number
RU96124465/14A
Other languages
Russian (ru)
Inventor
Е.А. Попов
Г.Н. Бисага
К.Е. Попов
О.В. Бабушкин
Original Assignee
Е.А. Попов
Г.Н. Бисага
К.Е. Попов
О.В. Бабушкин
Filing date
Publication date
Application filed by Е.А. Попов, Г.Н. Бисага, К.Е. Попов, О.В. Бабушкин filed Critical Е.А. Попов
Publication of RU96124465A publication Critical patent/RU96124465A/en

Links

Claims (1)

Способ лечения стойких дезадаптационных психовегетативных расстройств путем использования медикаментозных препаратов, отличающийся тем, что в качестве препарата используется "Содекор" в дозе 3 мл 3 раза в день в течение 1 месяца.A method for the treatment of persistent maladaptive psycho-vegetative disorders by using medications, characterized in that "Sodecor" is used as a preparation in a dose of 3 ml 3 times a day for 1 month.
RU96124465/14A 1996-12-27 METHOD FOR TREATMENT OF PERSISTENT DISADAPTATION PSYCHOPHETIC DISORDERS RU96124465A (en)

Publications (1)

Publication Number Publication Date
RU96124465A true RU96124465A (en) 1999-02-20

Family

ID=

Similar Documents

Publication Publication Date Title
NO20053106D0 (en) Oral, extended-release analgesic dosage form.
DE69427704D1 (en) NEW (R) -5-CARBAMOYL-8-FLUOR-3-N, N-DISUBSTITUTED-AMINO-3,4-DIHYDRO-2H-1-BENZOPYRANE
ZA962536B (en) Pharmaceutical composition for transdermal administration.
IT8621358A0 (en) PHARMACEUTICAL COMPOSITION ANALGESIC ADAPTIVITY.
MX9602683A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutically active substances.
MA22894A1 (en) PROCESS FOR THE PREPARATION OF A VACCINE.
CA2180535A1 (en) A method for treatment of psoriasis, by omeprazole or related compounds
AU1808595A (en) 3,8-diazabicyclo{3.2.1}octane derivatives having analgesic activity
GR3018009T3 (en) Use of gamma-hydroxybutyric acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism, and the compositions obtained.
DK0869808T3 (en) Use of Glu-Trp dipeptides for the preparation of a drug for the treatment of various conditions involving neovascularization
IT8323205A0 (en) PHARMACEUTICAL COMPOSITIONS ANTI-INFLAMMATORY AND/OR ANALGESIC ADAPTIVITY, NON-ULCEROGENIC.
ITRM920412A0 (en) HETEROPROSTANOIDS, PROCEDURE FOR THEIR PREPARATION AND THEIR THERAPEUTIC USE.
EE9400296A (en) Piperidinylthioindole derivatives, dosage forms, active analgesic, methods for their preparation
DE3576505D1 (en) 3,4-DIHYDROBENZOPYRANE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
TR199801184T2 (en) New compounds with analgesic action.
DE3380923D1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS CONDITIONED BY HUMAN DRUGS.
NO913162D0 (en) PHARMACEUTICAL PREPARATION FOR TONSILLITE TREATMENT.
RU96124465A (en) METHOD FOR TREATMENT OF PERSISTENT DISADAPTATION PSYCHOPHETIC DISORDERS
NO308583B1 (en) Use of steroids for the manufacture of a medicament for the treatment of disorders induced by estrogen deficiency, the steroids as well as pharmaceutical composition
ITRM920305A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF THE SHOCK, PARTICULARLY OF THE CARDIOGEN SHOCK AND SEPTIC SHOCK.
IT8026232A0 (en) PHARMACEUTICAL COMPOSITIONS. ALPHA-MERCAPTO PROPIONYLGLYCINE DERIVATIVE WITH THERAPEUTIC ACTIVITY, PROCEDURE FOR ITS PREPARATION AND RELATED
RU97117735A (en) METHOD FOR TREATING DIPHTERIA
RU96104214A (en) METHOD FOR TREATING TRANSSUDATIVE FORMS OF CENTRAL CHORIORETHINAL DYSTROPHIES
IT1288708B1 (en) PHARMACEUTICAL COMPOSITION INCLUDING THOMETAMINE FOR THE TOPICAL TREATMENT OF ACNE VULGARIS.
WO1994016705A3 (en) Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders